Clinical Trials Sponsored by Salus BKK

Total 1488 results

Universitätsklinikum Hamburg-Eppendorf
Federal Ministry of Health, Germany; BARMER; DAK Gesundheit; IKK Classic; AOK Rheinland... and other collaborators

Completed

Evaluation of a Cross-sectional Coordinated, Severity Stepped, Evidence-based Care Model for Mental Disorders (RECOVER)

Delivery of Health Care

Germany
Salus University

Terminated

Regimens of Intermittent Occlusion Therapy for Amblyopia in Children

Amblyopia

United States
Salus University

Unknown

Objective Assessment of Disparity Vergence After Treatment of Symptomatic CI in Children

Convergence Insufficiency

United States
Salus University

Completed

Binocular Vision Anomalies After Cataract and Refractive Surgery

Refractive Errors | Cataract | Binocular Vision Disorder

United States
Salus Ltd.

Unknown

Efficacy of Extracorporeal Shockwave Myocardial Revascularization (ANGEL)

Refractory Angina Pectoris

Hungary
Salus University

Not yet recruiting

Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma (NTG)

Normal Tension Glaucoma

United States
Salus University

Terminated

Bilateral and Unilateral Amblyopia Treatment Study

Amblyopia

United States
Salus University

Completed

Efficacy of an Intervention to Teach Zippering: A Two-Group Control Study

Typical Preschoolers Who Can Not Zipper

United States
Parc de Salut Mar
Instituto de Salud Carlos III

Completed

Abuse Liability and Human Pharmacology of Mephedrone

Amphetamine-Related Disorders

Spain
Parc de Salut Mar
Instituto de Salud Carlos III

Not yet recruiting

Suicide Prevention and Intervention in Spain: the SURVIVE Study (SURVIVE)

Depression | Suicide, Attempted | Suicide

Spain
Parc de Salut Mar
Instituto de Salud Carlos III

Recruiting

Breast Cancer Women on Aromatase Inhibitors Treatment (B-ABLE)

Osteoporosis | Osteoporosis Fracture | Arthralgia Generalized

Spain
Parc de Salut Mar
Instituto de Salud Carlos III

Terminated

Respiratory Muscle Training in Stroke Swallowing Disorders (RETORNUS-2)

Stroke | Malnutrition | Swallowing Disorder | Respiratory Muscle Training

Spain
Parc de Salut Mar
Instituto de Salud Carlos III

Unknown

Efficacy of an Online Program for the Treatment of Mild and Moderate Depression

Depression

Spain
Salus University

Active, not recruiting

Comparing Two Protocols to Improve Reflex Integration and Functional Performance

Developmental Delay

United States
Salus University

Completed

The Influence of Immersive Virtual Field Trips on Academic Vocabulary

Language Disorders in Children | Developmental Language Disorder

United States
Salus University

Unknown

Monitored Controlled Intermittent Alternate Occlusion (CIAO) Therapy for Intermittent Exotropia

Intermittent Exotropia

United States
Parc de Salut Mar
Instituto de Salud Carlos III

Recruiting

Implementing PROMs and PREMs in Routine Clinical Care: Assessment of Requirements and Impact (PROMs & PREMs)

PROMs | Implementation Research | PREMs | Impact Evaluation

Spain
Parc de Salut Mar
Instituto de Salud Carlos III

Completed

Mephedrone and Alcohol Interactions in Humans

Alcohol-Related Disorders | Amphetamine-Related Disorders

Spain
University of Luebeck
DAK Gesundheit; AOK Schleswig-Holstein; BEK Nord; Draeger and Hanse BKK; IKK Schleswig-Holstein and other collaborators

Completed

Medical In-Patient Rehabilitation in Rheumatoid Arthritis

Rheumatoid Arthritis

Germany
Consorci d'Atenció Primària de Salut de l'Eixample
Instituto de Salud Carlos III

Completed

Validity of 1BPM for Diagnosis of Hypertension

Hypertension

Spain
Salus University
Indiana University

Terminated

Efficacy of Intermittent Occlusion Therapy Glasses for Amblyopia

Amblyopia

United States
Salus Ltd.
TheraVitae Ltd.

Completed

Autologous Angiogenic Cell Precursors (ACPs) for the Treatment of Peripheral Artery Disease

Critical Limb Ischemia

Hungary
José Antonio Carrion
Instituto de Salud Carlos III

Completed

HBsAg Loss Adding Pegylated Interferon in HBeAg-negative Patients

Chronic Hepatitis B (HBeAg-negative)
Universidad de Zaragoza
Institut Català de la Salut; Salud Aragon; Universitat de Catalunya

Completed

Clinical Validation of a Decompression Prototype Splint for Patients With Carpal Tunel Syndrome

Carpal Tunnel Syndrome

Spain
Gilead Sciences
Salus Pharma, Inc.

Completed

Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

Cystic Fibrosis | Pseudomonas Aeruginosa | Lung Infection | CF

United States
Hospital del Mar Research Institute (IMIM)
Parc de Salut Mar; Instituto de Salud Carlos III

Recruiting

Improving Depressive Symptoms Through Personalised Exercise and Activation (IDEA)

Depressive Disorder | Depressive Symptoms

Spain
Salus Klinik Lindow
University of Cambridge

Recruiting

A Smartphone Based Intervention for the Prevention of Relapse in Alcohol Dependence (SPIRA)

Alcohol Dependence | Alcohol Use Disorder | Alcohol Abuse

Germany
Sun Yat-sen University
Salus University

Not yet recruiting

Office Based Vergence/Accommodative Therapy for the Treatment of Intermittent Exotropia

Intermittent Exotropia
Samus Therapeutics, Inc.

Terminated

A Single and Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of PU-AD in Healthy Subjects

Alzheimer's Disease

United States
Samus Therapeutics, Inc.

Terminated

Study of Icapamespib (PU-AD) in Patients With Recurrent Malignant Glioma (Glio)

Recurrent Glioblastoma Multiforme (GBM) | Grade 3 Isocitrate Dehydrogenase (IDH) Wildtype Astrocytoma | Grade 3 or 4 Astrocytoma | Glioblastoma Surgery

United States
Samus Therapeutics, Inc.

Withdrawn

A Study of Zelavespib (PU-H71) in Subjects With AP-MPN or BP-MPN (AP-MPN)

Accelerated Phase MPN | Blast Phase MPN
Biolab Sanus Farmaceutica

Withdrawn

Pharmacokinetics Trial of Isosorbide Mononitrate 0.5% Gel for Intra Anal Application in Healthy Subjects

Healthy Subjects | Pharmacokinetics
Biolab Sanus Farmaceutica

Unknown

Biolab Zolpidem Orodispersible 1.0 mg, 1.75 mg and 3.5 mg to Treat Maintenance Insomnia Disorder. (ZOLP_18_01)

Insomnia Disorder
Biolab Sanus Farmaceutica

Completed

Non-inferiority Trial of Dapaconazole Versus Ketoconazole

Tinea Pedis

Brazil
Biolab Sanus Farmaceutica

Completed

Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 3.5 mg Formulation

Healthy

Brazil
Biolab Sanus Farmaceutica

Completed

Pharmacokinetics Study of Zolpidem Hemitartarate Orodispersible Tablet 1.75 mg Formulation

Healthy

Brazil
Biolab Sanus Farmaceutica

Completed

Gastrointestinal Integrity After Naproxen + Rebamipide Versus Naproxen + Placebo

Gastrointestinal Lesions
Biolab Sanus Farmaceutica

Withdrawn

Pharmacokinetics of Eplerenone Tablet

Healthy Volunteers
Samus Therapeutics, Inc.

Terminated

Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking Ruxolitinib

Primary Myelofibrosis (PMF) | Post-Polycythemia Vera Myelofibrosis (Post-PV MF) | Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)

United States
Samus Therapeutics, Inc.

Withdrawn

Evaluate PU-AD in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)
Biolab Sanus Farmaceutica

Withdrawn

Pharmacokinetics Study of Eplerenone Coated Tablets

Healthy Subjects | Pharmacokinetics | Fasting

Brazil
Biolab Sanus Farmaceutica

Withdrawn

PK, PD and Safety Comparative Trial of Isosorbide Mononitrate Gel in Healthy Participants and With Anal Fissure

Anal Fissure
Biolab Sanus Farmaceutica

Completed

Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face (XEO-001/07)

Skin Aging

Brazil
Biolab Sanus Farmaceutica

Withdrawn

A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome

Postpoliomyelitis Syndrome

Brazil
Catcronic Salut SL

Not yet recruiting

Telemonitoring System for Improving Continuity of Care in Patients With Chronic Coronary Syndrome (TELSINCORC) (TELSINCORC)

Chronic Coronary Syndrome
Biolab Sanus Farmaceutica

Not yet recruiting

BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women.

Telogen Effluvium
Samus Therapeutics, Inc.

Terminated

To Evaluate Safety, Tolerability and Pharmacological Effects of PU AD in Subjects With Mild AD Dementia

Alzheimer Disease

United States
Samus Therapeutics, Inc.

Terminated

Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis

Primary Myelofibrosis | Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia Myelofibrosis

United States
Catcronic Salut SL

Completed

Rehabilitation After Acute Coronary Syndrome: a New Telemonitoring Strategy

Angina, Unstable | ST-segment Elevation Myocardial Infarction (STEMI) | Non-ST-Segment Elevation Myocardial Infarction (NSTEMI)

Spain
Biolab Sanus Farmaceutica

Withdrawn

Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%

Post-menopausal Period

Clinical Trials Sponsored by Salus BKK

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations